Verastem (VSTM) Other Non-Current Assets (2011 - 2026)
Verastem's (VSTM) quarterly Other Non-Current Assets came in at $241000.0 in Q1 2026, little changed year-on-year from $241000.0 in Q1 2025, and down 96.06% quarter-over-quarter from $6.1 million in Q4 2025.
Verastem (VSTM) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Verastem's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $241000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $241000.0 in Q1 2026; TTM through Mar 2026 was $241000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $6.1 million, up 24.76% from the prior year.
- Other Non-Current Assets retreated to $241000.0 in Q1 2026 per VSTM's latest filing, from $6.1 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $6.1 million in Q4 2025 and bottomed at $36000.0 in Q1 2023.
- The 5-year median for Other Non-Current Assets is $241000.0 (2022), against an average of $2.0 million.
- Across the five-year window, Other Non-Current Assets jumped 12608.33% in 2024 and plunged 94.73% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $241000.0 in 2022, then changed by 0.0% to $241000.0 in 2023, then jumped by 1932.78% to $4.9 million in 2024, then climbed by 24.76% to $6.1 million in 2025, then plunged by 96.06% to $241000.0 in 2026.
- Per Business Quant, the three latest VSTM Other Non-Current Assets figures stand at $241000.0 (Q1 2026), $6.1 million (Q4 2025), and $5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 241,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241,000.00 |
| Dec 31, 2025 | 6.11 Mn |
| Sep 30, 2025 | 5.34 Mn |
| Jun 30, 2025 | 5.37 Mn |
| Mar 31, 2025 | 241,000.00 |
| Dec 31, 2024 | 4.90 Mn |
| Sep 30, 2024 | 5.05 Mn |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 4.58 Mn |
| Dec 31, 2023 | 241,000.00 |
| Sep 30, 2023 | 241,000.00 |
| Jun 30, 2023 | 241,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 241,000.00 |
| Sep 30, 2022 | 47,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | 241,000.00 |
| Dec 31, 2021 | 241,000.00 |
| Sep 30, 2021 | 223,000.00 |
| Jun 30, 2021 | 103,000.00 |